AI brief of an SEC Form 8-K · Hims & Hers Health (HIMS)

Hims & Hers Q2 revenue rises 38% to $753.2 million; swings to $86.3 million net loss

Mixed Impact 4 of 5 earnings Written later

Hims & Hers reported second quarter 2026 revenue of $753.2 million, up 38% from a year earlier, and raised its full-year 2026 revenue guidance to $3.1 billion to $3.3 billion. The company swung to a net loss of $86.3 million from net income of $42.5 million in the prior-year quarter, and Adjusted EBITDA fell to $60.3 million from $82.2 million, so shareholders face higher revenue alongside lower profit.

Key points

  • Q2 2026 revenue was $753.2 million, up 38% year-over-year; subscribers reached 2,891 thousand, up 19%
  • Net loss was $86.3 million in Q2 2026 versus net income of $42.5 million in Q2 2025; gross margin fell to 64% from 76%
  • Adjusted EBITDA was $60.3 million versus $82.2 million a year earlier; Free Cash Flow was $(68.2) million
  • Full-year 2026 revenue guidance raised to $3.1 billion to $3.3 billion; Adjusted EBITDA guidance set at $275 million to $325 million

The filing

CompanyHims & Hers Health (HIMS)
Form8-K, current report
Filed with the SECAug 10, 2026, 4:08 PM ET
Accession number0001773751-26-000161

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 10, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.